Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-36,page-paged-36,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
    www.heidelberg-pharma.com
  • Rentschler Biopharma is once again featured on Germany’s top-ranked employers list
    www.rentschler-fill-solutions.com
  • Biom’up announces the approval of HEMOBLAST™ Bellows and its laparoscopic applicator in Australia
    www.biomup.com
  • Expedeon AG announces conversion to registered shares
    www.expedeon.com
  • Rentschler Biopharma announces enhanced collaboration with Summit Pharmaceuticals International Corporation to expand Japanese operation-base
    www.rentschler-fill-solutions.com
  • Motif Bio plc: Change of Adviser
    www.motifbio.com
  • Heidelberg Pharma AG announces adjustment of guidance
    www.heidelberg-pharma.com
  • Adocia Announces Receipt of USD 14.3 million Payment from Eli Lilly Following Arbitration Conclusion and the Decision by Mutual Consent with Eli Lilly to Conclude the Civil Case
    www.adocia.com
  • Biom’up: Approval of 2019 H1 interim results postponed – Board of Directors pursues review of options available to the Company
    www.biomup.com
  • Motif Bio plc: Motif Bio Reports Half-Year 2019 Financial Results, Operational Progress and Proposed Initiatives
    www.motifbio.com